Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TNKS2 divergent transcript (TNKS2-DT, also known as TNKS2-AS1 or TNKS2 antisense RNA 1 (head to head)), is a long non-coding RNA (lncRNA) gene located on human chromosome 10. It does not code for a protein and currently has no established function, recognized disease association, or validation as a therapeutic target. It is sometimes included in lncRNA catalogs, but there is no evidence to support its role as a receptor, enzyme, transporter, or drug target. Key distinctions: - This gene should not be confused with TNKS2 (Tankyrase 2), which is a well-characterized poly(ADP-ribose) polymerase family enzyme and a recognized therapeutic target. TNKS2-DT is an RNA transcript associated with, but distinct from, the protein-coding TNKS2 gene. - The current literature and gene databases do not document any direct functional, biomarker, or therapeutic role for TNKS2-DT. Summary: TNKS2 divergent transcript (TNKS2-DT) is a cataloged human lncRNA with limited biological characterization and no current application as a therapeutic target, biomarker, or subject of drug interaction studies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TNKS2 divergent transcript (TNKS2-DT).